SVCTF Stock UPDATES Senvest Capital Inc (SVCTF) 137.9940 09/10/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Senvest Capital Inc (SVCTF) 137.9940 $SVCTF

Senvest Capital Inc. Reports Results for the Second Quarter Ended June 30, 2014
Marketwire - Fri Aug 08, 5:17AM CDT
Senvest Capital Inc. (TSX: SEC) today reported a net loss of ($19.77) million or ($7.09) per share for the three months ended June 30, 2014. This compares to a net earnings of 45.27 million or $13.83 per share for the same period in 2013. For the six months ended June 30, 2014, the net earnings were $61.59 million or $17.74 per share, compared to net earnings of $138.27 million or $42.92 per share the prior year.

Senvest Capital Inc. Announces Acceptance by TSX of Normal Course Issuer Bid
CNW Group - Mon Jun 23, 9:42AM CDT
Senvest Capital Inc. (the "Corporation" (TSX: SEC) announced today the acceptance by the Toronto Stock Exchange (the "TSX" of the Corporation's Notice of Intention to make a normal course issuer bid (the "NCIB" . Pursuant to the NCIB, the Corporation proposes to purchase through the facilities of the TSX from time to time, if considered advisable, up to an aggregate of 130,000 of its common shares, being approximately 4.6% of its 2,801,624 issued and outstanding common shares as of June 16, 2014. However, due to the historically low volume of trading of its common shares on the TSX, the Corporation advises that actual purchases under the NCIB may in fact be significantly less than 130,000 shares. Purchases may commence through the TSX on June 25, 2014 and will conclude on the earlier of the date on which purchases under the bid have been completed and June 24, 2015.

Senvest Capital Reports Results for The Year Ended December 31, 2013
Marketwire - Thu Mar 27, 5:04PM CDT
Senvest Capital Inc. (TSX: SEC) today reported net income of $243.30 million or $73.20 diluted earnings per share for the year ended December 31, 2013. This compares to net income of $81.47 million or $25.65 diluted earnings per share for the year ended 2012.

Senvest Capital Inc. Announces Voting Results From its 2013 Annual Meeting of Shareholders
Marketwire - Mon Jun 03, 2:01PM CDT
Senvest Capital Inc. (the "Corporation" (TSX: SEC) is pleased to announce the voting results from its annual meeting of shareholders held on June 3, 2013 (the "Meeting" .

Senvest Capital Reports Results for the Quarter Ended March 31, 2013
Marketwire - Mon May 13, 3:01PM CDT
Senvest Capital Inc. (TSX: SEC) today reported net income of $93.0 million or $28.53 per share for the three months ended March 31, 2013. This compares to net income of $70.4 million or $22.34 per share for the same period in 2012.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

AbsenceSoft's AI Leave Planner Tackles HR Headaches

Updated Category News Views 77

Pioneering Technology in Leave Management AbsenceSoft is rolling out a tool that's about to shake up the HR world in a big way. MyAbsence, powered by AbsenceSoftAI, seems ready to cut down on the common confusions that send HR folks spinning around like they're in a two-step dance competition, juggling leave requests and compliance checks. It's all about getting the...

Continue Reading
Systemair Wins First Natural Refrigerant Heat Pump Deal

Updated Category News Views 87

Systemair Breaks New Ground Hold onto your hats, because Systemair just sealed a deal that's going to make waves. Their recent accomplishment isn't just some humdrum business tedium—it's an intriguing step forward in the HVAC world. Systemair snagged their very first order for air handling units featuring an integrated heat pump and natural refrigerant. You've got to...

Continue Reading
Natuvion and PwC's IT Roadbook: A Game-Changer?

Updated Category News Views 100

IT Transformations: A Tough Nut to Crack Transforming IT systems isn't just about plugging in new tech. It's a beast of a task, fraught with pitfalls and peopled with ambitious project managers hoping to dodge them. Natuvion and PricewaterhouseCoopers (PwC) have put together a book that could be the guide folks need when wading into these complex waters. The 'Why' of...

Continue Reading
Harbour BioMed's Strategic Nudge with Vivian Feng Hire

Updated Category News Views 17

A Refreshing Jolt for Harbour BioMed's Growth Journey Harbour BioMed just threw down a new card by bringing in Ms. Vivian Feng as the Senior Vice President, Head of External Collaboration. There's a real sense of drive coming from this decision. When a biopharma outfit asserts its intent to ramp up growth, and they hang the hat on someone like Vivian, you better believe...

Continue Reading
MY DR NOW Expands: Seven-Day Clinics Open Everywhere

Updated Category News Views 54

Breaking The Mold Of Traditional Medicine MY DR NOW isn't here to play by the age-old rules. They're slinging open the doors to their newest family medicine clinics and kicking the old Monday-to-Friday scheduling straight to the curb. Every single day of the week, from 8 a.m. to 8 p.m., patients in Sunnyvale and Tucson are getting a dose of healthcare that's all about...

Continue Reading
Cincoro Tequila Unveils Rare Añejo for Holidays

Updated Category News Views 92

Firing Up the Holiday Spirit with Cincoro Well, isn't this a timely toast to class? As if the tequila scene wasn't already brimming with options, Cincoro's decided to paint the town gold with a rare addition to its lineup. For those of you who treat your liquor collection like a stockpile of fine art, here's something that'll turn heads this holiday season—the Añejo...

Continue Reading
Charming Holiday Inflatables Add Festive Flair

Updated Category News Views 60

Small Spaces, Big Holiday Spirit Not everyone’s got the sprawling front yard of a mansion to decorate, but that doesn’t mean you have to miss out on holiday cheer. Gemmy’s latest pint-sized holiday inflatables hit the market this season, aiming straight for those of us with cozy porches and snug apartments. These little guys might measure only 3 to 5 feet tall, but...

Continue Reading
Ophthalmic Equipment Market Set for Growth Surge by 2031

Updated Category News Views 79

Eyeing the Road Ahead: Vital Market Growth Insights We've got ourselves a sector on the move. The ophthalmic equipment market, pegged at USD 21.2 billion in 2026, is set to climb up to a whopping USD 30.5 billion by 2031. Knowing that it’s growing at a steady clip of 7.5% CAGR over these years, there’s more than just a glimmer of opportunity for those savvy enough to...

Continue Reading
RingConn Joins BVB Women's Team: Tech Meets Sport

Updated Category News Views 64

Tech and Football: An Unlikely Alliance Alright, so here's a story that might perk your ears up—RingConn, a relative newcomer in the health tech world, has chosen to stake its future on a bet with Borussia Dortmund's women's football team. This isn't just your average brand-sponsorship slap-on-the-shirt deal; we're looking at a potential game-changer here, folks. Who...

Continue Reading
Bluevua Triumphs with Three BASA Awards Wins

Updated Category News Views 48

Bluevua Sweeps the 2026 BASA Awards Stacking accolades like old trading wins, Bluevua just clinched not one, not two, but three 2026 Best of America Small Business Awards (BASA Awards®). If that's not a feather in their cap, I don't know what is. For the uninitiated, these BASA nods are no small potatoes—they're like the Oscars for small businesses. Bluevua, known for...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding P/E Ratios: What It Means for CSWC Investors

Updated Category News Views 86

Evaluating the P/E Ratio of Capital Southwest Currently, Capital Southwest Inc. (NASDAQ: CSWC) shares are trading at $21.52, reflecting a modest increase of 0.09%. Over the past month, the stock has seen a rise of 2.82%, while the yearly growth stands at 1.65%. Such performance tends to encourage long-term investors, but it also prompts others to scrutinize the...

Continue Reading
Roche's Lunsumio: Pioneering Subcutaneous Treatment for Lymphoma

Updated Category News Views 170

Roche’s Breakthrough with Lunsumio Roche is making significant strides in the treatment of follicular lymphoma with its innovative subcutaneous formulation of Lunsumio, a bispecific antibody designed to engage T-cells in battling this common form of non-Hodgkin lymphoma. Following a favorable recommendation from the European Medicines Agency’s Committee for Medicinal...

Continue Reading
Ayush Mittal Takes the Helm at Trianz for Digital Transformation

Updated Category News Views 470

Ayush Mittal Joins Trianz as Global Head of DT Services Trianz, an industry leader in digital transformation software and services, has recently announced the appointment of Ayush Mittal as its Senior Vice President and Global Head of Digital Transformation (DT) Services. Extensive Industry Experience With almost 30 years of rich experience in IT Infrastructure and Cloud...

Continue Reading
Discover Luxury Living: Quick Move-In Homes from Toll Brothers

Updated Category News Views 206

Introducing Quick Move-In Homes by Toll Brothers Recently, Toll Brothers, Inc. has unveiled a unique opportunity for homebuyers looking for luxurious living in a serene environment. Located in a beautiful setting, their Northfield community is designed to provide families with quick access to quality living. With a selection of move-in ready and quick move-in homes,...

Continue Reading
Nyxoah SA Announces Key Transparency Notification Details

Updated Category News Views 154

Nyxoah SA rocked the boat back in September 2024 when it revealed a transparency notification that set tongues wagging on the trading floor. The culprit? None other than BlackRock Advisors, LLC, which tumbled below that all-important 3% ownership threshold. If you think that's just numbers, think again; this shift speaks volumes about market dynamics and investor...

Continue Reading